Citation: Pj. Schwingl et J. Shelton, MODELED ESTIMATES OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLIC-DISEASE IN USERS OF 2ND-GENERATION AND 3RD-GENERATION ORAL-CONTRACEPTIVES, Contraception, 55(3), 1997, pp. 125-129
Citation: Pj. Schwingl, ORAL-CONTRACEPTIVES, PREGNANCY AND THE RISK OF CEREBRAL THROMBOEMBOLISM - THE INFLUENCE OF DIABETES, HYPERTENSION, MIGRAINE AND PREVIOUS THROMBOTIC DISEASE, British journal of obstetrics and gynaecology, 103(1), 1996, pp. 93-94
Authors:
SCHILDKRAUT JM
SCHWINGL PJ
BASTOS E
EVANOFF A
HUGHES C
Citation: Jm. Schildkraut et al., EPITHELIAL OVARIAN-CANCER RISK AMONG WOMEN WITH POLYCYSTIC-OVARY-SYNDROME, Obstetrics and gynecology, 88(4), 1996, pp. 554-559
Citation: Cs. Morrison et Pj. Schwingl, ORAL-CONTRACEPTIVE USE AND INFECTIVITY OF HIV-SEROPOSITIVE WOMEN, JAMA, the journal of the American Medical Association, 270(19), 1993, pp. 2298-2298